These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14683592)

  • 21. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.
    Layek B; Lipp L; Singh J
    J Control Release; 2015 Jun; 207():143-53. PubMed ID: 25886704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice.
    Davis HL; Brazolot Millan CL; Mancini M; McCluskie MJ; Hadchouel M; Comanita L; Tiollais P; Whalen RG; Michel ML
    Vaccine; 1997 Jun; 15(8):849-52. PubMed ID: 9234531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES.
    Kim SJ; Suh D; Park SE; Park JS; Byun HM; Lee C; Lee SY; Kim I; Oh YK
    Virology; 2003 Sep; 314(1):84-91. PubMed ID: 14517062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.
    Böhm W; Mertens T; Schirmbeck R; Reimann J
    Vaccine; 1998; 16(9-10):949-54. PubMed ID: 9682342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration.
    Gramzinski RA; Millan CL; Obaldia N; Hoffman SL; Davis HL
    Mol Med; 1998 Feb; 4(2):109-18. PubMed ID: 9508788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyvalent DNA vaccines with bidirectional promoters.
    Kwissa M; Unsinger J; Schirmbeck R; Hauser H; Reimann J
    J Mol Med (Berl); 2000; 78(9):495-506. PubMed ID: 11140375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
    Liang ZW; Ren H; Lang YH; Li YG
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
    Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.
    Grenfell RF; Shollenberger LM; Samli EF; Harn DA
    Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation.
    Peng JL; Zhao YG; Mai JH; Pang WK; Guo W; Chen GM; Mo GY; Rao GR; Xu YH
    Acta Pharmacol Sin; 2007 Jul; 28(7):1024-30. PubMed ID: 17588339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
    Schirmbeck R; Reimann J
    Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling.
    Zou Q; Zhong Y; Su H; Kang Y; Jin J; Liu Q; Geng S; Zhao G; Wang B
    Vaccine; 2010 Feb; 28(8):2032-8. PubMed ID: 20188260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Boosting with HBV subunit particle vaccine enhance immune response of novel DNA vaccine consisting of S-PreS1 fusion gene in mice].
    Chen H; Deng Y; Tan W; Wang W; Guan J; Wen B; Yin X; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):95-100. PubMed ID: 21553495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
    Lu M; Isogawa M; Xu Y; Hilken G
    J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
    Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
    J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.
    March JB; Clark JR; Jepson CD
    Vaccine; 2004 Apr; 22(13-14):1666-71. PubMed ID: 15068849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.